- Professor Lees receives Jay Van Andel Award for Outstanding Research in Parkinson’s Disease
- Creating brain cells from skin to study Alzheimer's
- Queen Square authors prominent in Brain collection of classic articles
- Toxic proteins implicated in frontotemporal dementia and motor neurone disease
- Double mutation linked to frontotemporal dementia
- Equation to predict happiness
- Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia
- Researchers test whether diabetes drug can help Parkinson’s patients
- Acute optic neuritis: a review and proposed protocol
- Hippocampal subfield size predicts the precision of memory recall
- Immune system implicated in dementia development
- UCL and Chiesi Group announce partnership to develop a novel therapeutic for birth asphyxia
- Professor Golay made a Fellow of the ISMRM
- The new Leonard Wolfson Experimental Neurology Centre (LWENC) has opened for clinical studies and trials
- Professor Rees wins UCLU Student Choice Teaching Award
- New epilepsy treatment offers ‘on demand’ seizure suppression
- Professor Tabrizi and Professor Price elected to Fellowship of the Academy of Medical Sciences.
- Professor Dolan and Professor Friston elected to EMBO membership
- Vitamin B3 treatment for ataxia shows promise in first human trial
- Teaching Awards 2014
- Light-activated neurons from stem cells restore function to paralysed muscles
- UCL and Max Planck Society invest €5m to open world’s first computational psychiatry centre
- Successful launch of new annual leading edge neurology course
- Statins could help control MS
- Professor Hardy awarded Thudichum Medal by Biochemical Society
- Population Screening for vCJD Using a Novel Blood Test
- Chief Medical Officer appoints Professor Rossor as NIHR National Director for Dementia Research
- New partnership between UCLP brain tumour scientists and Brain Tumour Research
- Professor Hardy awarded Dan David Prize for work on the amyloid gene encoding APP
- NIHR award £650,000 for research into rare neurodegenerative and neuromuscular diseases
- Lowering levels of toxic protein reverses abnormalities in cells from patients with Huntington's disease
- Major initiative in understanding synaptic basis of neuropsychiatric disease
- Visit to the Berlin School of Mind and Brain
- Institute of Neurology ranked as the world’s top institution for epilepsy research.
- Predicting age at onset in SCA1 : does size matter?
- UCL takes the lead with £8.5m funding for dementia research
- Secretary of State visits leading dementia research projects
- Riboflavin Treatment for Childhood onset Motor Neuron Disease
- Dreading pain can be worse than pain itself
- Different gene expression in male and female brains helps explain differences in brain disorders
- New £20m centre pioneers first-in-man trials for neurodegenerative diseases
- RNA build-up linked to dementia and motor neuron disease
- Researchers estimate one in 2,000 people in the UK carry variant CJD proteins
- Professor Alan Thompson discusses Atlas of MS on Lancet News
- Wellcome Trust Principal Fellowship award to explore neural coding with the tripartite synapse
- Marsden's Book of Movement Disorders wins Neurology first prize at the 2013 BMA Book Awards
- Scientists develop refined diagnostic tool for inherited dementias
- Genetic mutations linked to Parkinson's Disease
- P-glycoprotein over-activity and drug resistance in temporal lobe epilepsy
- New Yale-UCL collaboration in brain aneurysm genetics
- ‘Risky’ stroke prevention procedure may be safe in some patients
- The Michael J. Fox Foundation awards grant for Exenatide research
- Institute Professor leads cross-disciplinary study on use of glucose in detecting cancer.
- Irreversible tissue loss seen within 40 days of spinal cord injury
- From Bedside to Bench in the Institute’s MRC Centre for Neuromuscular Diseases
- Centralising acute stroke services has saved more than 400 lives since 2010
- Rapid Response Innovation Award from The Michael J. Fox Foundation
- Predicting Language Outcome and Recovery After Stroke (PLORAS) project launches new website
- BRC awards over £500k to neuroscience projects
- ABTA Winners
- Diabetes drug could help treat Parkinson's Disease
- Clinical trials are vital tools in stroke research
- New gene identified for Dominant Congenital Spinal Muscular Atrophy and Hereditary Spastic Paraparesis
- Teaching Awards 2013
- 14th Annual Queen Square Symposium
- TRACK-HD study identifies early predictors of disease progression in Huntington’s disease
- The Great Brain Experiment: crowdsourcing data on how we think and act
- Psychogenic diseases linked to abnormal brain activity
- Human Brain Project wins major EU funding
- Gene mutation causes familial form of cranio-cervical dystonia
- Professor Ray Dolan awarded prestigious Klaus Joachim Zülch Prize
- Professor Dimitri Kullmann elected Editor of Brain
- IoN News Archive (2012)
- IoN News Archive (2011)
- IoN News Archive (2010)
- IoN News Archive (2009)
- GCH1 gene and Parkinson’s risk
Published: Aug 12, 2014 1:23:13 PM
Published: Feb 20, 2014 6:58:34 PM
Published: Sep 16, 2013 1:37:21 PM
Published: Feb 24, 2014 2:53:53 PM
Published: Jul 16, 2014 5:42:14 PM
Published: Sep 3, 2014 11:00:13 AM
UCL and Max Planck Society invest €5m to open world’s first computational psychiatry centre
3 April 2014
The world’s first centre for computational psychiatry was launched on Tuesday 1st April, following a €5m investment from the Max Planck Society and UCL.
The Max Planck UCL Centre for Computational Psychiatry and Ageing Research will develop computational methods to understand how human cognition works and how it becomes disrupted in psychiatric disorders, such as depression, and how it changes with normal cognitive ageing.
Computational approaches aim to bridge the gap between neuroscience and the phenomena seen in psychiatric disorders, by developing models of how the brain works. The models will then be linked to measurements of behaviour and changes in brain function. This will help to identify the causes of a range of mental health problems so that personalised treatments can be developed.
The Centre will be based between UCL (University College London) and the Max Planck Institute for Human Development in Berlin. It will be led by Professor Ray Dolan FRS, Director at the Wellcome Trust Centre for Neuroimaging, UCL Institute of Neurology, and Professor Ulman Lindenberger, Director at the Max Planck Institute for Human Development.
The Centre aspires to spearhead new perspectives on psychiatric disorders that will realise major benefits for patients within 5-10 years. One focus will be rethinking the very nature of psychiatric disorders by moving from simply describing them to understanding how they develop. In diseases such as cancer, understanding how different processes give rise to the disease has opened up exciting new personalised treatment strategies. The Centre will aim to do the same for psychiatric diseases. For example, many people think of depression as a single disorder but this umbrella term is likely to cover a number of distinct processes that could be better-treated with personalised therapies.
Professor Ray Dolan FRS
In most countries of the world, the older segment of the adult population is increasing. There is a pressing need to identify and strengthen the environmental conditions and biological mechanisms that favour mental fitness in later adulthood and old age. Maintaining cognitive abilities and postponing or preventing pathologies leading to dementia are key aims in this endeavour. Ageing alters the neurochemistry, anatomy, and functional dynamics of the brain. We will combine advanced brain imaging methods with computational methods to classify and predict aging changes at the individual level.
Professor Ulman Lindenberger
I welcome the commitment and international collaboration from UCL and the Max Planck Society on this ground-breaking initiative that demonstrates the importance of research into mental illness. The new facility will help to address the challenges posed by mental health problems for neuroscience itself and demonstrate the need to harness cutting edge neuroscience to tackle the problem.
Science Minister David Willetts
The opening event at the Royal Society on 1st April featured welcome speeches from key figures including UCL President & Provost Professor Michael Arthur, Max Planck Society President Peter Gruss, Science Minister David Willetts, Professor Ray Dolan and Professor Ulman Lindenberger. The keynote lecture was delivered by Nobel laureate Professor Eric Kandel, Director at The Kavli Institute for Brain Science at Columbia University.
Page last modified on 03 apr 14 11:48